-
UK investing in “strategic” AI capabilities
OpenBind consortium, new Centre for AI-driven innovation, and supercomputer funding all intended to help drive drug R&D
-
GRIP Extra: SEC to cut enforcement staff by 17%, Wells Fargo freed from asset cap
Our in-brief roundup also includes Bristol Myers Squibb and BioNTech in a drug partnership, Reddit suing Anthropic for using its data, and BlackRock being removed from Texas blacklist.
-
GRIP Extra: Bitcoin hits record high, SEC commissioner slams deregulation
Other news includes China threatening legal action against companies taking US guidance not to buy Chinese chips, and the UK sanctioning an accountant for buying oil tankers for Lukoil.
-
Drug prices in executive and legislative cross-hairs
The rising cost of prescription drugs is a concern for patients, healthcare providers and policymakers, but crafting a solution without undermining industry confidence is tricky.
-
GRIP Extra: Coinbase victim of $400m cyberattack, Trump fires Copyright Office director
Other news includes Nvidia planning an R&D center in Shanghai, the SEC and FINRA withdrawing a joint crypto custody statement, and the CEO of Novo Nordisk stepping down.
-
Assertio Therapeutics dinged $3.6m over fentanyl false claims
The settlement is the latest in a string of False Claims Act enforcement actions against pharmaceutical companies.
-
FDA announces AI rollout timeline and scientific review pilot completion
The FDA said its timing to scale use of AI inside its FDA centers follows the completion of a GenAI pilot for scientific review.
-
GRIP Extra: TikTok fined €530m, Kohl’s CEO dismissed
Other news includes the CFPB moving to scrap Biden-era medical debt credit reporting exemption, the EU reciprocally seizing billions of Russian funds, and the DOJ accusing CVS, Humana, Elevance of paying kickbacks.